Clinical Trial Update: Lentiviral FVIII Gene Therapy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a lentiviral factor VIII gene therapy for hemophilia A is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Lentiviral FVIII gene therapy

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Hemophilia A | Phase 1 | Status: RECRUITING